Top Clicks This Month

Not Intended for Therapeutic Use. For research use only.

NSI-189 - CAS 1270138-40-3

Quick Inquiry

Name:
* Email:
* Service & Products of Interest:
* Quantity:
* Verification code:
Please input "bocsci" as verification code.
Category
Inhibitor
Product Name
NSI-189
Catalog Number
1270138-40-3
Synonyms
NSI-189; NSI 189; NSI189
CAS Number
1270138-40-3
Description
NSI-189 is an experimental drug being studied by Neuralstem, Inc. Research into NSI-189 has been funded by the Defense Advanced Research Projects Agency (DARPA) and the National Institutes of Health (NIH) for the treatment of major depressive disorder. NSI-189 successfully completed a phase 1 clinical trial in 2011 where it was administered to 41 healthy volunteers. A phase 1b clinical trial for treating major depressive disorder in 24 patients started in 2012 and completed in July 2014. The study suggests that there were improvements in the patients' condition when the doses were 40/80 mg per day, but no significant improvements were seen for a higher dosage of 120 mg/day. Neuralstem intends to pursue further clinical trials for a variety of neurological conditions, including major depressive disorder, traumatic brain injury, Alzheimer's disease, post-traumatic stress disorder, stroke, and natural cognitive and memory decline in aging.
Molecular Weight
366.5
Molecular Formula
C22H30N4O
Quantity
Grams-Kilos
Quality Standard
Enterprise Standard
COA
Certificate of Analysis-NSI-189 1270138-40-3 B15JP0412  
MSDS
Inquire
Current Developer
Neuralstem, Inc.
Structure
CAS 1270138-40-3 NSI-189
Specification
Purity
98%
Appearance
Off-white powder
Application
For research used only
2005 - BOC Sciences | All rights reserved
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE